| 19:30 |
Business Meeting |
| 19:40 |
Scientific Meeting:
“Current Status of MRI in Drug Discovery” |
| |
19:45
Potential Uses of Magnetic Resonance Imaging in Development of Therapies
for Atheroma
Zahi A. Fayad, The Eva and Morris Feld Cardiovascular MRI Research
Laboratory, Mount Sinai School of Medicine,
New York, New York, USA |
| |
20:10
Applications of MRI in the Development of Drugs for Musculoskeletal
Disorders
John Waterton, Discovery Enabling Capabilities & Sciences, AstraZeneca,
Alderly Edge, United Kingdom |
| |
20:35 MRI in
the Development of Drugs for Neurological Disorders: An Industry View
Paul Matthews, GlaxoSmithKline, London, England, UK |
| |
21:00
Biomarker Consortium Update
Jeffrey L. Evelhoch, Medical Sciences – Imaging, Amgen, Inc., Thousand
Oaks, California, USA |
| |
21:15 Panel
Discussion |
| |
|
|